Cap Raise Crucible: Canaccord leads big mining dash for cash
Roundup of 35 ASX capital raisings seeking a combined $687.5m in late August and early September, led by mining deals; Canaccord Genuity topped the broker table and three IPOs floated.
Investor · 2 deals
Joint lead manager for placement
Every published round Blue Ocean Equities took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Broken Hill Mines | Unnamed stage | 11 Sep 2026 | $90m | Participant | The Age Business, SMH Business | |
| Thinxtra | Bridge / extension | Jun 2023 | $5m | Participant | SmartCompany, ARN (ARNnet) |
Companies Blue Ocean Equities has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Thinxtra | IoT solutions for asset tracking, smart facilities and utilities | Jun 2023, Bridge / extension | 1 | 0 |
| Broken Hill Mines | 11 Sep 2026 | 1 | 0 |
Fund closes reported for Blue Ocean Equities, as distinct from the investments it has made.
Companies Blue Ocean Equities has backed that another company then bought. An exit for the holding, not a deal Blue Ocean Equities did.
Stories naming Blue Ocean Equities. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of 35 ASX capital raisings seeking a combined $687.5m in late August and early September, led by mining deals; Canaccord Genuity topped the broker table and three IPOs floated.
Roundup tallies 35 ASX equity fundraises seeking $687.5 million, mostly miners; Canaccord Genuity led broker mandates with nine deals, while FireFly Metals' $190 million package was the period's largest.
Also The Age Business
Melbourne biotech Percheron Therapeutics has locked in $2.3 million through an institutional placement to fund a Vanderbilt Health trial of its HMBD-002 antibody in blood cancers.
ASX-listed Pathkey.AI has completed a A$2.8 million placement anchored by former Altium chairman Sam Weiss, who becomes a strategic advisor as the company advances its Chipforge chip-design automation technology.
Weekly roundup detailing seven Australian startup raises totalling $16.4 million, covering Thinxtra, Canopus Networks, Mash, Beamible, Earthodic, Citadel.run and Cleverbean, with investors, amounts and founder backgrounds.